These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3518743)

  • 1. Effector mechanisms in allograft rejection.
    Mason DW; Morris PJ
    Annu Rev Immunol; 1986; 4():119-45. PubMed ID: 3518743
    [No Abstract]   [Full Text] [Related]  

  • 2. Effector mechanisms in renal allograft rejection.
    Tax WJ; Koene RA
    Nephrol Dial Transplant; 1995; 10(9):1569-71. PubMed ID: 8559471
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA and renal transplantation.
    Carpenter CB
    N Engl J Med; 1980 Apr; 302(15):860-2. PubMed ID: 6987517
    [No Abstract]   [Full Text] [Related]  

  • 4. Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection.
    Bradley JA; Mowat AM; Bolton EM
    Immunol Today; 1992 Nov; 13(11):434-8. PubMed ID: 1362058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of renal allograft rejection].
    Michel F
    Ann Urol (Paris); 1988; 22(3):161-7. PubMed ID: 3041909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of allograft rejection].
    Charpentier B
    Presse Med; 1984 Dec; 13(44):2697-700. PubMed ID: 6240035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory factors in pregnancy: essential or irrelevant in the maintenance of the fetoplacental allograft?
    Billington WD; Bell SC
    Placenta Suppl; 1982; 4():13-23. PubMed ID: 6242564
    [No Abstract]   [Full Text] [Related]  

  • 9. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunobiology of transplant rejection.
    Häyry P
    Ann Clin Res; 1981; 13(4-5):172-98. PubMed ID: 7039479
    [No Abstract]   [Full Text] [Related]  

  • 11. Histocompatibility in humans.
    Fotino M
    Ann Clin Lab Sci (1971); 1971; 1(2):125-30. PubMed ID: 4405210
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lymphocytes in transplantation immunity--in the relation to HLA antigens].
    Takata H
    Hum Cell; 1988 Sep; 1(3):275-81. PubMed ID: 2979204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of allograft rejection: the roles of cytotoxic T-cells and delayed-type hypersensitivity.
    Mason DW; Dallman MJ; Arthur RP; Morris PJ
    Immunol Rev; 1984; 77():167-84. PubMed ID: 6370832
    [No Abstract]   [Full Text] [Related]  

  • 14. Cells mediating allograft rejection.
    Hall BM; Dorsch SE
    Immunol Rev; 1984; 77():31-59. PubMed ID: 6232202
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of rejection and prolongation of vascularized organ allografts.
    Tilney NL; Kupiec-Weglinski JW; Heidecke CD; Lear PA; Strom TB
    Immunol Rev; 1984; 77():185-216. PubMed ID: 6232201
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic control of transplant rejection.
    Butcher GW; Howard JC
    Transplantation; 1982 Oct; 34(4):161-6. PubMed ID: 6815843
    [No Abstract]   [Full Text] [Related]  

  • 17. The tolerance that develops in recipients of cultured allografts is an active process that affects both the activation and effector function of cytotoxic T cells.
    Talmage DW; La Rosa FG; Smilek D; Ammons TJ
    Prog Clin Biol Res; 1986; 224():187-94. PubMed ID: 3491996
    [No Abstract]   [Full Text] [Related]  

  • 18. Doubts and uncertainties about the nature of allotransplanted organs.
    Dempster WJ
    Jpn J Exp Med; 1973 Oct; 43(5):357-68. PubMed ID: 4590255
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor-soluble histocompatibility antigen selectively potentiates suppressor elements while decreasing the frequency of alloantigen-specific T cytotoxic cells.
    Stepkowski SM; Ghobrial R; Wang B; Ito Y; Goto S; Hamashima T; Kahan BD
    Transplant Proc; 1993 Oct; 25(5):2875. PubMed ID: 8212270
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune mechanisms in organ allograft rejection: IV. An overview of adoptive transfer studies on the pathogenesis of homograft rejection in the inbred rat.
    Lowry RP; Forbes RD
    Transplant Proc; 1985 Aug; 17(4):1963-5. PubMed ID: 3161226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.